What Is Metoprolol Tartrate For? Uses and Side Effects

Metoprolol tartrate is a prescription beta-blocker used primarily to treat high blood pressure, chest pain from angina, and heart failure. It works by selectively blocking beta-1 receptors in the heart, which slows the heart rate, reduces the force of each heartbeat, and lowers blood pressure. The “tartrate” designation refers to the specific salt form of the drug, which is the immediate-release version, and that distinction turns out to matter more than most people realize when it comes to dosing schedules and clinical evidence.

How Metoprolol Tartrate Works

Your body has a stress-response system driven by adrenaline and related hormones. When these hormones bind to beta-1 receptors on the heart, your heart beats faster and harder. In conditions like high blood pressure or heart failure, the sympathetic nervous system is often in overdrive, flooding the heart with signals that push it to work beyond its capacity. Beta-blockers like metoprolol step in to block those receptors, dampening the effect of that constant stimulation.

In heart failure specifically, this matters because the failing heart is stuck in a vicious cycle: it pumps poorly, so the body releases more adrenaline to compensate, which strains the heart further. Clinical research has shown that beta-blockers reduce both the likelihood of getting sicker and the risk of death in heart failure patients by interrupting that cycle, preventing harmful remodeling of the heart muscle, and gradually improving how well the heart pumps.¹

Approved Uses

Metoprolol tartrate is prescribed for three main conditions. The first and most common is high blood pressure. It is often used alongside a diuretic (a “water pill”), and that combination has been shown to be safe and well tolerated in mild hypertension.² The second is angina pectoris, the chest pain that occurs when the heart muscle does not get enough blood flow. By slowing the heart and reducing its oxygen demand, metoprolol helps prevent angina episodes. The third approved use is after a heart attack, where starting a beta-blocker early can reduce the risk of a second event.

In heart failure, metoprolol is also widely used, though this is where the distinction between the tartrate and succinate forms becomes clinically relevant, which we will get to shortly. A study tracking over 3,000 person-years of beta-blocker use in heart failure patients found that metoprolol tartrate accounted for about 42% of all beta-blocker exposure, and its risk of rehospitalization was comparable to that of carvedilol and atenolol after adjusting for patient differences.³

Tartrate Versus Succinate

This is one of the most common points of confusion. Metoprolol comes in two forms: tartrate (immediate-release) and succinate (extended-release). The drug itself is the same molecule, but the way your body absorbs it differs substantially. Metoprolol tartrate has a half-life of roughly 3 to 4 hours, which means it clears your system relatively quickly and typically needs to be taken twice a day. Metoprolol succinate, with a half-life of 3 to 7 hours and a controlled-release design, is dosed once daily and produces more stable blood levels throughout the day.⁴

The practical upshot is that succinate provides smoother, more consistent beta-blockade with less fluctuation between peak and trough drug levels. That consistency may help with medication adherence since you only take it once a day, and it may also reduce the kind of hemodynamic ups and downs that come with the peaks and valleys of a twice-daily drug.⁵

Here is where things get interesting for heart failure specifically: metoprolol succinate is the form that was studied in the major trial proving that metoprolol reduces mortality in heart failure, and it is the form officially approved for that indication. Metoprolol tartrate is not technically approved for heart failure, even though it is commonly prescribed for it in practice. A head-to-head hemodynamic comparison of the two formulations in 27 heart failure patients found no significant difference in functional improvement, exercise capacity, or hemodynamic benefits during long-term treatment.⁶ But the gap in formal evidence is a point of ongoing debate among cardiologists, and your doctor may have specific reasons for choosing one over the other.

Migraine Prevention

Beyond its cardiovascular uses, metoprolol has a solid evidence base for preventing migraines. A double-blind trial comparing metoprolol to propranolol (the beta-blocker most commonly associated with migraine prevention) found the two drugs clinically equivalent in reducing attack frequency and severity.⁷ A large systematic review and meta-analysis confirmed that metoprolol reduces headache frequency by close to one attack per month compared to placebo, an effect rated as moderate-quality evidence.⁸

A separate review looking at all oral migraine prevention drugs found that beta-blockers as a class reduced migraine days by about 1.3 per month compared to placebo in people who averaged around 8 migraine days per month at baseline, which put them on par with topiramate and amitriptyline.⁹ If you have both high blood pressure and frequent migraines, metoprolol can address both problems simultaneously.

Common Side Effects

Most side effects from metoprolol tartrate are mild. Fatigue and dizziness are the complaints that show up most consistently across studies.¹⁰ One trial in people with mild hypertension specifically reported mild fatigue as the most frequent complaint, with occasional reports of cold extremities, dizziness, and headache.²

In heart failure patients, side effects tend to be reported at higher rates since these patients are sicker to begin with. A clinical-practice survey of heart failure patients on beta-blockers found that weight gain, fatigue, dizziness, and shortness of breath were the most commonly reported issues.¹¹ Keep in mind that in heart failure, it can be difficult to separate drug side effects from the disease itself: fatigue and shortness of breath are also symptoms of the condition being treated.

Vivid Dreams and Nightmares

One side effect that catches many people off guard is unusually vivid dreams or outright nightmares. Metoprolol is a lipophilic (fat-soluble) drug, which means it crosses into the brain more easily than water-soluble beta-blockers like atenolol. Once in the central nervous system, it can disrupt the normal pattern of REM sleep, alter noradrenaline signaling, and suppress melatonin production, all of which may contribute to intense, emotionally charged dreams.¹²

This is not just a theoretical concern. Patients prescribed metoprolol for migraine prevention have reported vivid dreams severe enough to warrant switching medications. Studies have confirmed that the more fat-soluble a beta-blocker is, the more likely it is to cause these central nervous system effects.¹³ If sleep disturbances are a problem for you, your doctor may consider switching to a more water-soluble alternative.

Drug Interactions Worth Knowing About

Metoprolol is broken down in the liver by an enzyme called CYP2D6. Any drug that inhibits this enzyme can dramatically increase metoprolol levels in your blood, making side effects far more likely. The most clinically significant culprits are certain antidepressants. Paroxetine, for example, has been shown to increase metoprolol blood levels by three to five times, with measurable drops in blood pressure and heart rate.¹⁴

Fluoxetine (Prozac) works through the same mechanism. Other drugs that can raise metoprolol levels include amiodarone (a heart rhythm drug), celecoxib (an anti-inflammatory), cimetidine (a heartburn medication), terbinafine (an antifungal), and even diphenhydramine (Benadryl).¹⁵ If you are starting or stopping any medication while on metoprolol, it is worth asking your pharmacist to check for interactions.

Genetics also play a role. Some people are naturally “poor metabolizers” of CYP2D6, meaning their bodies clear metoprolol slowly even without interfering drugs. These individuals may experience stronger effects at standard doses. This is not something most people know about themselves unless they have had pharmacogenomic testing.

What Happens If You Stop Suddenly

You should not stop metoprolol tartrate abruptly. Research has documented a clear rebound effect after sudden withdrawal: in one study, patients who had their metoprolol stopped cold saw an average 15% rebound rise in resting heart rate and a 52% increase in the heart’s sensitivity to adrenaline-like stimulation within two to eight days.¹⁶ In patients with coronary artery disease, even gradual withdrawal produced a rebound increase in heart rate that persisted for about three weeks, along with the potential for ischemic symptoms to emerge.¹⁷

The bottom line is that if you and your doctor decide to discontinue metoprolol, the dose should be tapered gradually over one to two weeks. This is especially important if you have any form of heart disease, where a sudden spike in heart rate and blood pressure could trigger angina or, in rare cases, a heart attack.

Metoprolol and Exercise

Because metoprolol slows the heart rate, it inevitably affects exercise capacity. Studies in healthy people show that at typical therapeutic doses, maximum heart rate drops by roughly 40 to 50 beats per minute, and peak exercise capacity decreases by about 5 to 8%.¹⁸ Higher intravenous doses have also been shown to reduce maximum oxygen uptake and available blood sugar during peak exercise.¹⁹

In a comparison with carvedilol (a non-selective beta-blocker), metoprolol tartrate blunted the heart rate response more at every exercise intensity and produced a greater reduction in peak oxygen consumption.²⁰ If you are an athlete or someone who exercises vigorously, this is worth discussing with your doctor. For most people, the effect is noticeable but manageable. You may just find that your “hard” effort at the gym feels different because your heart rate is capped at a lower ceiling than before. Heart rate-based training zones become unreliable on beta-blockers, so perceived effort becomes a better guide.

Taking Metoprolol Tartrate with Food

Unlike some medications that need to be taken on an empty stomach, metoprolol tartrate should actually be taken with food or shortly after a meal. Research has shown that food enhances the bioavailability of metoprolol, meaning your body absorbs more of the drug when food is present.²¹ Prescribing labels generally recommend taking it with or immediately following meals. This also has the practical advantage of tying your doses to regular meals, which can help with consistency since the tartrate form needs to be taken twice daily.

Special Populations

Several groups of people require special attention when using metoprolol tartrate.

Liver Disease

Because metoprolol is processed almost entirely by the liver, people with significant liver disease absorb much more of each dose into their bloodstream. In patients with liver cirrhosis, roughly 84% of an oral dose reaches the blood, compared to about 50% in healthy people.²² That is a dramatic difference and may require significant dose reductions. A systematic review of metoprolol’s pharmacokinetics confirmed that clearance drops in cirrhosis compared to healthy subjects.²³

Kidney Disease

Kidney function, by contrast, has surprisingly little effect on metoprolol levels. Since less than 5% of the drug is eliminated unchanged through the kidneys, even significant renal impairment does not meaningfully change how long the drug stays in your system. One study found that the elimination half-life was nearly identical between people with kidney failure and healthy volunteers.²⁴ This makes metoprolol a relatively straightforward choice in people with chronic kidney disease who need a beta-blocker.

Breastfeeding

For new mothers who need a beta-blocker, metoprolol is considered one of the safest options. It is excreted into breast milk at low levels, and a review of cardiovascular medication safety during lactation identified metoprolol as the preferred beta-blocker, with the most reassuring safety data available for nursing mothers.²⁵

Metoprolol and Diabetes

There is a longstanding concern that beta-blockers can mask the symptoms of low blood sugar in people with diabetes and make it harder for the body to recover from a hypoglycemic episode. The reality with metoprolol is more nuanced than the warning suggests. A study in people with insulin-dependent diabetes found that a single dose of metoprolol did not make blood sugar drop lower, and the body’s counter-regulatory hormones (the ones that help raise blood sugar back to normal) actually increased under metoprolol. Sweating was enhanced, not suppressed, and other hypoglycemia symptoms were unchanged.²⁶

A separate study in healthy volunteers confirmed that metoprolol did not worsen the blood sugar drop caused by insulin and did not mask symptoms of hypoglycemia, though recovery to normal blood sugar levels was slightly delayed in the later phases.²⁷ In practice, metoprolol is used regularly in diabetic patients, but it is worth being aware that the traditional warning signs of low blood sugar, like a racing heartbeat, may be blunted since slowing the heart rate is exactly what the drug does. Sweating, hunger, and shakiness are more reliable cues if you are on a beta-blocker.

Asthma and Lung Disease

Beta-2 receptors live in the lungs, and blocking them can cause airway constriction. Metoprolol is “cardioselective,” meaning it preferentially targets the beta-1 receptors in the heart rather than the beta-2 receptors in the lungs. But that selectivity is not absolute, particularly at higher doses. A large observational study found that cardioselective beta-blockers like metoprolol were associated with a higher rate of emergency department visits in patients with asthma, though the risk was far lower than with non-selective beta-blockers, which roughly doubled the hospitalization rate in asthma patients.²⁸

In people with COPD alone (no asthma), the picture is somewhat different. Cardioselective beta-blockers were actually associated with a lower rate of hospitalization compared to controls in this population. The takeaway is that asthma is the lung condition where metoprolol requires the most caution. If you have asthma and your doctor prescribes metoprolol, it should be started at a low dose with close monitoring. Many people with mild asthma tolerate it fine, but it is a situation that requires careful, individualized judgment.

Overdose

Metoprolol overdose is a medical emergency. Because the drug slows the heart and reduces its contractile force, a large overdose can lead to dangerously low heart rate and blood pressure, progressing to cardiovascular collapse. Case reports describe patients who ingested massive amounts of metoprolol tartrate failing to respond to standard treatments like glucagon, atropine, and vasopressors. In one case, a patient who took roughly 7,500 mg required extracorporeal membrane oxygenation (essentially a machine that does the heart’s and lungs’ work) because no other intervention could maintain adequate circulation.²⁹ In another case involving a similar dose, lipid emulsion therapy and high-dose insulin given during cardiac arrest led to a return of a heartbeat.³⁰

These are extreme scenarios, but they illustrate why metoprolol, like all prescription medications, should be stored securely and taken only as directed. If an overdose is suspected, call emergency services immediately. Standard home first aid is not sufficient for beta-blocker toxicity.

Older Adults and Dose Variability

Metoprolol blood levels can vary enormously from person to person. Research tracking the drug’s behavior in young versus elderly volunteers found that blood concentrations after repeated dosing were higher than what would be predicted from single-dose data, and elderly patients may accumulate more of the drug over time.³¹ This variability, combined with the CYP2D6 genetic differences and drug interactions discussed earlier, means that two people taking the same dose of metoprolol may end up with very different amounts of active drug in their bloodstream. If you feel that your dose is too strong or too weak, it is worth raising the question with your prescriber rather than assuming the dose is simply “right” because it is standard.

1
Europe PMC. Mechanisms of the beneficial effects of beta-adrenoceptor antagonists in congestive heart failure
2
Drug Development Research. Antihypertensive effect of metoprolol in diuretic‐treated, mild primary hypertension
3
PubMed Central. Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure
4
Journal of Cardiac Failure – Intersections. Differential Impact of Metoprolol Formulations on Heart Failure Outcomes: A Multicenter Study – Section: Results
5
PubMed. Extended-release metoprolol succinate in chronic heart failure
6
PubMed. Hemodynamic comparison of twice daily metoprolol tartrate with once daily metoprolol succinate in congestive heart failure
7
PubMed. Metoprolol and propranolol in migraine prophylaxis: a double-blind multicentre study
8
PLoS ONE. Beta-blockers for the prevention of headache in adults, a systematic review and meta-analysis – Section: Results
9
PubMed Central. Drugs for Migraine Prophylaxis – Section: Results
10
Vascular & Endovascular Review. Comparative Study of Metoprolol Succinate and Metoprolol Tartrate: Therapeutic Efficacy and Safety through Oral and Nasogastric Tube Administration – Section: Results
11
PubMed. Tolerability to beta-blocker therapy among heart failure patients in clinical practice – Section: RESULTS
12
PubMed Central. Vivid Dreams and Nightmares as an Adverse Effect of Beta-Blockers in the Treatment of Episodic Migraine
13
Medical News and Research Review. Metoprolol and Nightmares: Understanding the Connection – Section: Lipophilicity and Blood-Brain Barrier Penetration
14
PubMed Central. The impact of CYP2D6 mediated drug–drug interaction: a systematic review on a combination of metoprolol and paroxetine/fluoxetine – Section: Results
15
PubMed. A Review on Pharmacokinetic and Pharmacodynamic Drug Interactions of Adrenergic β-blockers with Clinically Relevant Drugs-An Overview
16
PubMed. Metoprolol withdrawal phenomena: mechanism and prevention
17
American Heart Journal. Rebound phenomena following gradual withdrawal of chronic metoprolol treatment in patients with ischemic heart disease
18
PubMed. Maximal aerobic power and blood pressure in normotensive subjects after acute and chronic administration of metoprolol
19
PubMed. Effects of acute and chronic metoprolol administration during submaximal and maximal exercise
20
PubMed. Randomized, double-blind comparison of acute beta1-blockade with 50 mg metoprolol tartrate vs 25 mg carvedilol in normal subjects
21
PubMed. Enhancement of the bioavailability of propranolol and metoprolol by food
22
PubMed. Pharmacokinetics of metoprolol in patients with hepatic cirrhosis
23
PubMed. Clinical Pharmacokinetics of Metoprolol: A Systematic Review – Section: RESULTS
24
PubMed. Pharmacokinetic and pharmacodynamic properties of metoprolol in patients with impaired renal function
25
American Heart Journal Plus: Cardiology Research and Practice. Lactation safety of cardiovascular medications – Section: Hypertension / Heart failure / Arrhythmias
26
PubMed. Effects of metoprolol on the counter-regulation and recognition of prolonged hypoglycemia in insulin-dependent diabetics
27
Metabolism. Beta blockade and diabetes mellitus: Effect of oxprenolol and metoprolol on the metabolic, cardiovascular, and hormonal response to insulin-induced hypoglycemia in normal subjects
28
PubMed Central. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers – Section: MEASUREMENTS AND MAIN RESULTS
29
PubMed Central. Massive metoprolol overdose requiring ECMO: brief review of the evidence behind recommended treatments
30
PubMed. Successful treatment of a massive metoprolol overdose using intravenous lipid emulsion and hyperinsulinemia/euglycemia therapy
31
PubMed Central. The effect of age on the pharmacokinetics of metoprolol and its metabolites